RNA - Dyne Therapeutics on deck for IPO August, 26 2020 06:36 AM Avidity Biosciences Inc. Dyne Therapeutics (DYN) has filed a preliminary prospectus for a $100M IPO.More news on: Dyne Therapeutics, Inc., Sarepta Therapeutics, Inc., Nippon Shinyaku Co. Ltd., Healthcare stocks news, IPO News, , Read more ...